Multiple Sclerosis Trial, Recruiting NCT07550699 Sponsor: ABLE Human Motion S.L. Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07550699
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 80 years old
  • People who have been diagnosed with an acquired brain injury, a spinal cord injury (at a specific level and severity range, confirm with trial site), or multiple sclerosis
  • People who are currently receiving physiotherapy treatment, either as a hospital inpatient or an outpatient, at the centre running the trial
  • People who are able to give their own informed consent to participate

Who may not be able to join:

  • People with significant bone thinning (osteoporosis) that may raise the risk of broken bones
  • People with unhealed fractures in the pelvis or legs, or who have had a fragility fracture in the lower limbs within the past 2 years
  • People with an unstable spine, or who use a spinal brace unless medically approved
  • People whose spinal cord injury neurological assessment has worsened notably in the past 4 weeks, or who have new loss of sensation or movement above their injury level that has not yet been assessed by a doctor
  • People with severe muscle stiffness (rated at level 4 on a standard medical scale)
  • People who are unable to tolerate being upright for at least 10 minutes due to a drop in blood pressure
  • People with uncontrolled autonomic dysreflexia (a condition affecting automatic body functions, common in spinal cord injury)
  • People who are medically unstable
  • People with an unstable heart or circulation condition, uncontrolled high blood pressure, a blood clot in a deep vein (DVT), or uncontrolled autonomic dysreflexia
  • People with serious other health conditions that the trial investigator considers unsuitable for using the exoskeleton device or completing the study
  • People with pressure sores or skin wounds of any grade in areas where the device would make contact with the body
  • People whose height is outside the range of 1.5 to 1.9 metres, or who weigh more than 100 kg
  • People with physical body characteristics (such as a significant difference in leg length) that make it impossible to fit or use the device safely
  • People with joint movement limitations that prevent normal walking or sitting-to-standing movements, including restricted movement at the ankle, knee, or hip (confirm specific degree requirements with trial site)
  • People with abnormal bone growth in soft tissue (a condition called heterotopic ossification)
  • People who are pregnant or breastfeeding
  • People with cognitive difficulties that prevent them from following simple instructions or completing study procedures
  • People who require assisted breathing (mechanical ventilation)
  • People with a significant spinal curvature (scoliosis) above a certain degree (confirm with trial site)
  • People who have a pacemaker, defibrillator, or other electronic implant that is not compatible with the study device
  • People with open wounds, infections, or active skin irritation at the sites where electrodes would be placed
  • People with severe skin conditions in the areas where stimulation would be applied
  • People with active epilepsy that is not well controlled
  • People with a malignant tumour (cancer) in the area where the device would be applied
  • People with severe loss of sensation in the areas where electrodes would be placed
  • People whose doctor considers electrical stimulation to be medically inadvisable for them
  • People who are unable to communicate pain, discomfort, or any adverse reactions during stimulation
  • People with venous blood clots, inflammation of the veins, or severe blockage of arteries
  • People with chronic vein problems with significant varicose veins
  • People with haemophilia (a blood clotting disorder)
  • People with an ongoing infection or fever
  • People who have metal implants in the area through which the electrical current from the electrodes would pass

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +43 681 207 41241

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ABLE Human Motion S.L.
Registry
ClinicalTrials.gov
Start date
20 April 2026
Est. completion
12 August 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Number and type of device-related Adverse Events; Time taken to don/doff the device; Number of steps walked; Distance walked; Time spent upright and time spent walking; Number of therapists assisting the session; Assistive device used; Step Length; Step Symmetry; Center of mass displacement (cm); Motor torque (Nm)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov